Navigation Links
Marken Meets Critical Demand For In Vitro Lab Shipments
Date:5/7/2013

RESEARCH TRIANGLE PARK, N.C., May 7, 2013 /PRNewswire/ -- Marken is experiencing significant growth in demand for their specialized handling and shipments of biopsied embryo cells to laboratories across the US.  These cells are often used in Pre-Implantation Genetic Diagnostic Testing (PGD) and to diagnose certain diseases and conditions during in vitro fertilization (IVF) treatments.  Marken is well known for its highly personalized service which requires that the samples are placed in customized, temperature controlled containers and rapidly transported to specialized laboratories, where they are tested, often within 24 hours.  With time being such a critical element, the demand for Marken's logistical services continues to grow with the increased demand for IVF and PGD services.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO)

Marken is 100% dedicated to the life sciences industry, which makes them uniquely qualified to work with IVF clinics and PGD laboratories, universities and research centers that provide these services to patients.

Wes Wheeler , Marken's Chief Executive Officer, believes more and more laboratories are turning to Marken for this type of specialized service. He commented, "We do whatever it takes to deliver these irreplaceable samples under any circumstances.  The coordination and dedication between our local Marken staff and their laboratory customers is both impressive and heartwarming. The samples may arrive anytime during the day or night and our teams will stay until the last sample is delivered. We understand our role in delivering to the laboratories as quickly and as safely as possible. It's a powerful mission."

IVF can be a complex and expensive procedure, increasing the critical nature of selecting a specialized courier who can guarantee on-time delivery and careful handling of their samples.  An international committee estimates that the total number of IVF births has reached five million worldwide. With such a longstanding history in the pharma industry, Marken is poised to continue to lead and grow the challenging dynamics of supplying logistics to the market for Assisted Reproductive Technologies.

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

www.marken.com


'/>"/>
SOURCE Marken
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Marken Launches Exclusive Shipping System for Specimen Logistics
2. Marken Opens Two Pharmaceutical Depots In New York & Germany
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Chimerix Antiviral Compound, CMX001, Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients
5. When nerve meets muscle, biglycan seals the deal
6. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
7. Human Genome Decoder and Artificial Life Creator, J. Craig Venter to Speak at "The Atlantic Meets the Pacific"
8. Veridiams Training Program Wins Accolades and Awards- Meets Skilled Labor Challenge Head On
9. Origami meets chemistry in scholarly video-article
10. SPIE ‘gold’ open access program meets new needs of UK authors -- and others
11. Berkeley Lab seeks to help US assert scientific leadership in critical materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... material that exhibits both viscous and elastic characteristics when deformed, which is identical ... exhibits properties to gently absorb compressive forces and return to its natural state ...
(Date:3/23/2017)... , Mar 23, 2017 Research and ... Global Markets" report to their offering. ... The Global Market ... Billion in 2016 at a CAGR of 8.9%, ... and non-energetic bioproducts into seven major product segments: bio-derived chemicals, ...
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical ... reported financial results for the quarter and year ... update on the company,s clinical development efforts and ... pleased to report that last year was a ... Krammer. "We achieved key clinical milestones and attracted ...
Breaking Biology Technology:
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
Breaking Biology News(10 mins):